What are reasons Korean pharmas rarely develop novel drugs on their own?

Published: 2017-12-27 16:16:17

Updated: 2017-12-27 16:48:07

Korean pharmaceutical companies have rarely produced self-developed novel drugs.

According to the Ministry of Food and Drug Safety(MFDS), since ‘Sunpla Inj,’ a SK Chemicals’ anticancer drug, acquired approval as the first Korean drug in 1999, total 28 products have been approved as Korean drug by the year of 2017.

With pharmaceutical companies’ R&D investments, surprisingly 4 products were...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.